Value of information analysis in healthcare: a review of principles and applications

References

• Lyman GH, Levine M. Comparative effectiveness research in oncology: an overview. J Clin Oncol Official J Am Soc Clin Oncol 2012;30:4181-4
   PubMed Web of Science ®Google Scholar
• Sculpher M, Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty–when is there sufficient evidence? Value Health 2005;8:433-46
   PubMed Web of Science ®Google Scholar
• Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008;26:781-98
   PubMed Web of Science ®Google Scholar
• Eckermann S, Willan AR. Time and expected value of sample information wait for no patient. Value Health 2008;11:522-6
   PubMedGoogle Scholar
• Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-64
   PubMed Web of Science ®Google Scholar
• Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ 2007;16:195-209
   PubMed Web of Science ®Google Scholar
• Steuten L, van de Wetering G, Groothuis-Oudshoorn K, et al. A systematic and critical review of the evolving methods and applications of value of information in academia and practice. Pharmacoeconomics 2013;31:25-48
   PubMed Web of Science ®Google Scholar
• Eckermann S, Karnon J, Willan AR. The value of value of information best informing research design and prioritization using current methods. Pharmacoeconomics 2010;28:699-709
   PubMedGoogle Scholar
• Claxton K, Palmer S, Longworth L, et al. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess 2012;16:1-323
   PubMed Web of Science ®Google Scholar
• Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996;5:513-24
   PubMed Web of Science ®Google Scholar
• Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006;24:1055-68
   PubMed Web of Science ®Google Scholar
• Tuffaha HW, Rickard CM, Webster J, et al. Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Appl Health Econ Health Policy 2014;12:51-8
   PubMedGoogle Scholar
• Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Mak 2004;24:207-27
   PubMed Web of Science ®Google Scholar
• Willan AR, Goeree R, Boutis K. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning. J Clin Epidemiol 2012;65:870-6
   PubMedGoogle Scholar
• Willan AR. Sample size determination for cost-effectiveness trials. Pharmacoeconomics 2011;29:933-49
   PubMed Web of Science ®Google Scholar
• Willan AR, Pinto EM. The value of information and optimal clinical trial design. Stat Med 2005;24:1791-806
   PubMed Web of Science ®Google Scholar
• McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Med Decis Mak 2011;31:853-65
   PubMed Web of Science ®Google Scholar
• Fleurence RL. Setting priorities for research: a practical application of ‘payback' and expected value of information. Health Econ 2007;16:1345-57
   PubMedGoogle Scholar
• Davies L, Drummond M, Papanikolaou P. Prioritizing investments in health technology assessment. Can we assess potential value for money? Int J Technol Assess Health Care 2000;16:73-91
   PubMed Web of Science ®Google Scholar
• Chilcott J, Brennan A, Booth A, et al. The role of modelling in prioritising and planning clinical trials. Health Technol Assess 2003;7:1-138
   PubMedGoogle Scholar
• Fleurence RL, Meltzer DO. Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups. Med Decis Making 2013;33:460-2
   PubMedGoogle Scholar
• Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in oncology: the value of evidence and evidence of value. J Oncol Pract 2014;10(2):e55-e62
   PubMedGoogle Scholar
• Longworth L, Youn J, Bojke L, et al. When does NICE recommend the use of health technologies within a programme of evidence development?: a systematic review of NICE guidance. Pharmacoeconomics 2013;31:137-49
   PubMedGoogle Scholar
• Walker S, Sculpher M, Claxton K, et al. Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions. Value Health 2012;15:570-9
   PubMed Web of Science ®Google Scholar
• Willan AR, Eckermann S. Value of information and pricing new healthcare interventions. Pharmacoeconomics 2012;30:447-59
   PubMed Web of Science ®Google Scholar
• Koerkamp BG, Spronk S, Stijnen T, et al. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication. Value Health 2010;13:242-50
   PubMedGoogle Scholar
• Stevenson MD, Jones ML. The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate. Med Decis Mak 2011;31:43-52
   PubMed Web of Science ®Google Scholar
• Koerkamp BG, Nikken JJ, Oei EH, et al. Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example. Radiology 2008;246:420-5
   PubMedGoogle Scholar
• Soares MO, Dumville JC, Ashby RL, et al. Methods to assess cost-effectiveness and value of further research when data are sparse: negative-pressure wound therapy for severe pressure ulcers. Med Decis Mak 2013;33:415-36
   PubMedGoogle Scholar
• Myers E, Sanders GD, Ravi D, et al. Evaluating the potential use of modeling and value-of-information analysis for future research prioritization within the evidence-based practice center program. Rockville, MD: Agency for Healthcare Research and Quality, 2011. Available from: http://www.ncbi.nlm.nih.gov/books/NBK62134 [Last accessed January 2014]
   Google Scholar
• Carlson JJ, Thariani R, Roth J, et al. Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med Decis Mak 2013;33:463-71
   PubMedGoogle Scholar
• Sadatsafavi M, Bansback N, Zafari Z, et al. Need for Speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value Health 2013;16:438-48
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Marra C, Bryan S. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials. Health Econ 2013;22:877-88
   PubMed Web of Science ®Google Scholar
• Brennan A, Kharroubi SA. Efficient computation of partial expected value of sample information using Bayesian approximation. J Health Econ 2007;26:122-48
   PubMed Web of Science ®Google Scholar
• Brennan A, Kharroubi S, O'Hagan A, et al. Calculating partial expected value of perfect information via Monte Carlo sampling algorithms. Med Decis Mak 2007;27:448-70
   PubMed Web of Science ®Google Scholar
• Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Med Decis Mak 2008;28:21-32
   PubMed Web of Science ®Google Scholar
• Philips Z, Claxton K, Palmer S. The half-life of truth: what are appropriate time horizons for research decisions? Med Decis Mak 2008;28:287-99
   PubMed Web of Science ®Google Scholar
• Willan AR, Eckermann S. Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ 2010;19:549-61
   PubMed Web of Science ®Google Scholar